UNICA IRIS Institutional Research Information System

FRAU, JESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 275.551
NA - Nord America 12.225
AS - Asia 5.658
SA - Sud America 872
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 11
Totale 294.474
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 272.535
US - Stati Uniti d'America 12.049
SG - Singapore 2.261
CN - Cina 1.979
BR - Brasile 671
SE - Svezia 607
UA - Ucraina 587
VN - Vietnam 505
DE - Germania 469
FI - Finlandia 350
FR - Francia 302
GB - Regno Unito 297
HK - Hong Kong 184
IN - India 140
KR - Corea 98
CA - Canada 95
NL - Olanda 84
AR - Argentina 73
BD - Bangladesh 60
IQ - Iraq 55
MX - Messico 52
RU - Federazione Russa 47
ZA - Sudafrica 46
AT - Austria 45
TR - Turchia 44
ES - Italia 41
PK - Pakistan 35
PL - Polonia 35
MA - Marocco 32
JP - Giappone 31
CZ - Repubblica Ceca 30
PH - Filippine 28
ID - Indonesia 26
UZ - Uzbekistan 25
VE - Venezuela 24
EC - Ecuador 23
SA - Arabia Saudita 23
CO - Colombia 22
BE - Belgio 21
MY - Malesia 21
CL - Cile 20
EU - Europa 17
IL - Israele 16
IE - Irlanda 14
JO - Giordania 14
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
KE - Kenya 11
LT - Lituania 11
AU - Australia 10
DZ - Algeria 10
GR - Grecia 10
NP - Nepal 10
OM - Oman 10
PS - Palestinian Territory 10
TN - Tunisia 10
EG - Egitto 9
HU - Ungheria 9
PE - Perù 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
PY - Paraguay 8
DO - Repubblica Dominicana 7
RS - Serbia 7
TH - Thailandia 7
BO - Bolivia 6
CR - Costa Rica 6
LB - Libano 6
MD - Moldavia 6
TW - Taiwan 6
AL - Albania 5
DK - Danimarca 5
RO - Romania 5
SN - Senegal 5
BG - Bulgaria 4
CH - Svizzera 4
EE - Estonia 4
ET - Etiopia 4
KW - Kuwait 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BH - Bahrain 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
MM - Myanmar 2
MU - Mauritius 2
PR - Porto Rico 2
SI - Slovenia 2
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 294.450
Salva come PNG Salva come JPEG
Città #
Cagliari 266.119
Uta 5.480
Ashburn 1.244
Singapore 1.128
Fairfield 1.055
Woodbridge 784
San Jose 609
Dallas 604
Chandler 579
Houston 510
Wilmington 471
Boardman 465
Seattle 404
Beijing 387
Cambridge 382
Ann Arbor 365
Nyköping 349
Los Angeles 321
Chicago 283
Jacksonville 273
Helsinki 236
Dearborn 187
New York 182
Lauterbourg 162
Hong Kong 161
Santa Clara 160
The Dalles 157
Nanjing 153
Ho Chi Minh City 147
Shanghai 141
Munich 140
Buffalo 138
Hefei 137
Salt Lake City 130
Boston 117
Council Bluffs 107
Hanoi 96
Seoul 96
Milan 90
Elk Grove Village 68
Tampa 64
São Paulo 63
San Diego 61
Rome 60
Norwalk 58
Shenyang 55
Guangzhou 54
Nanchang 47
Orem 47
Dong Ket 46
Redwood City 46
Toronto 45
Washington 42
Atlanta 41
Jiaxing 40
London 40
Redondo Beach 40
Hebei 37
Sterling 35
Brooklyn 32
Frankfurt am Main 32
Phoenix 32
Sassari 32
Tianjin 31
Verona 29
Vienna 28
Warsaw 28
Amsterdam 27
Da Nang 27
Hangzhou 26
Nuremberg 26
Lancaster 25
Changsha 24
Düsseldorf 24
Mexico City 24
Miami 24
Tokyo 24
Johannesburg 23
Stockholm 23
Chennai 21
Columbus 21
Denver 20
Domusnovas 20
Montreal 20
Tashkent 20
Turku 20
Xi'an 20
Baghdad 19
Mountain View 19
Shenzhen 19
Zhengzhou 19
Detroit 17
Jinan 17
Brussels 16
Casablanca 16
Dulles 16
Naples 15
Taizhou 15
Brno 14
Dublin 14
Totale 286.457
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.157
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.966
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.936
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.575
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.483
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.299
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.216
Overexpression of the cytokine BAFF and autoimmunity risk 4.105
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.036
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.008
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.924
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.899
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.880
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.837
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.814
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.730
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.660
Walking improvements with nabiximols in patients with multiple sclerosis 3.648
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.616
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.607
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.586
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.584
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.506
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.433
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.405
Impact of the media on future hope in multiple sclerosis 3.381
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.313
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.304
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.282
Oral agents in multiple sclerosis 3.209
Influence of treatments in multiple sclerosis disability: a cohort study 3.178
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.162
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.110
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.055
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.040
Refining the connection between gait and cognition: training the body to improve the brain 2.980
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.978
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.975
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.874
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.870
Postural adaptation during a Nintendo Wii balance training 2.667
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.638
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.621
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.556
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.532
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.443
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.403
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.330
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.326
The cohort of the multiple sclerosis center of Cagliari 2.320
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.312
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.284
Induction and escalation therapies in multiple sclerosis 2.279
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.256
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.242
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.225
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.206
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study 2.111
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.093
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.068
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.061
Clinical activity after fingolimod cessation: disease reactivation or rebound? 1.965
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.957
Epidemiology of multiple sclerosis in south-western Sardinia 1.925
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.813
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.807
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.748
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis 1.719
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.698
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.645
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.639
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 1.612
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls 1.606
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 1.601
Association of Mycobacterium avium subsp. paratuberculosis and SLC11A1 polymorphisms in Sardinian multiple sclerosis patients 1.561
Association of Mycobacterium avium subsp paratuberculosis with Multiple Sclerosis in Sardinian Patients 1.559
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients 1.552
Timed Up and Go in men and women with Multiple Sclerosis: effect of muscular strength 1.545
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients 1.496
Monoclonal antibodies: a target therapy for multiple sclerosis 1.478
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.403
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.390
Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study 1.373
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.351
Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study 1.342
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 1.337
Progressive multiple sclerosis and mood disorders 1.315
Delayed effect of age at onset on disability progression in multiple sclerosis 1.301
The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis 1.292
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 1.292
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers 1.289
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up 1.254
PML in a person with multiple sclerosis: Is teriflunomide the felon? 1.232
Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia? 1.213
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis 1.212
The burden of multiple sclerosis and patients' coping strategies 1.178
Effect of different dosages of interferon beta-1a in relapsing remitting MS patients 1.143
Coenzyme Q10 in the CSF of MS patients 1.137
Q10 in the CSF of MS patients 1.124
Gait initiation evaluation in multiple sclerosis 1.099
Totale 254.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 358.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 358.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.288 0 0 0 0 0 0 0 0 0 4.032 3.841 2.415
2021/202212.748 1.740 811 509 1.140 1.076 743 514 626 1.361 1.315 1.601 1.312
2022/202317.134 1.459 2.510 2.363 1.485 1.472 1.711 777 1.379 980 979 1.288 731
2023/202418.811 1.099 962 833 1.260 1.750 3.239 2.200 1.879 949 1.296 1.700 1.644
2024/202561.458 20.721 19.853 6.452 3.738 2.015 2.220 3.213 213 604 567 1.278 584
2025/202611.174 885 583 1.185 1.151 937 897 2.479 1.198 742 1.117 0 0
Totale 295.177